Enhabit’s (EHAB) “Market Perform” Rating Reaffirmed at Leerink Partners

Leerink Partners reissued their market perform rating on shares of Enhabit (NYSE:EHAB) in a research report sent to investors on Tuesday morning,Benzinga reports. The firm currently has a $8.00 price target on the stock, down from their prior price target of $8.50.

Enhabit Stock Performance

Enhabit stock opened at $7.56 on Tuesday. The stock has a market cap of $380.12 million, a P/E ratio of -3.28 and a beta of 1.84. The company has a current ratio of 1.46, a quick ratio of 1.46 and a debt-to-equity ratio of 0.85. The stock has a 50 day moving average of $7.52 and a 200-day moving average of $8.41. Enhabit has a 52 week low of $6.85 and a 52 week high of $11.74.

Enhabit (NYSE:EHAB) last released its earnings results on Wednesday, November 6th. The company reported $0.03 EPS for the quarter, missing the consensus estimate of $0.04 by ($0.01). The business had revenue of $253.60 million for the quarter, compared to analysts’ expectations of $261.69 million. Enhabit had a negative net margin of 11.24% and a positive return on equity of 1.67%. During the same quarter last year, the company posted $0.03 earnings per share. On average, analysts expect that Enhabit will post 0.25 EPS for the current fiscal year.

Hedge Funds Weigh In On Enhabit

Several large investors have recently added to or reduced their stakes in EHAB. FMR LLC lifted its stake in Enhabit by 138.4% during the third quarter. FMR LLC now owns 3,388 shares of the company’s stock worth $27,000 after purchasing an additional 1,967 shares during the last quarter. Gladius Capital Management LP acquired a new stake in Enhabit in the second quarter worth $31,000. Quarry LP increased its position in Enhabit by 242.2% in the second quarter. Quarry LP now owns 3,703 shares of the company’s stock worth $33,000 after buying an additional 2,621 shares during the period. Allspring Global Investments Holdings LLC acquired a new stake in Enhabit in the first quarter worth $44,000. Finally, Stoneridge Investment Partners LLC acquired a new stake in Enhabit in the third quarter worth $81,000.

About Enhabit

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.